The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.

Saved in:
Bibliographic Details
Title: The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.
Authors: Fader AN; Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: afader1@jhmi.edu., Java J; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY, USA., Krivak TC; Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, USA., Bristow RE; University of California Irvine, Orange, CA, USA., Tergas AI; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Bookman MA; Arizona Cancer Center, Tucson, AZ, USA., Armstrong DK; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Tanner EJ; Johns Hopkins Medical Institutions, Baltimore, MD, USA., Gershenson DM; University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
Source: Gynecologic oncology [Gynecol Oncol] 2014 Mar; Vol. 132 (3), pp. 560-5. Date of Electronic Publication: 2013 Dec 13.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 24333362
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fader+AN%22">Fader AN</searchLink>; Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address: afader1@jhmi.edu.<br /><searchLink fieldCode="AU" term="%22Java+J%22">Java J</searchLink>; Gynecologic Oncology Group Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY, USA.<br /><searchLink fieldCode="AU" term="%22Krivak+TC%22">Krivak TC</searchLink>; Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bristow+RE%22">Bristow RE</searchLink>; University of California Irvine, Orange, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tergas+AI%22">Tergas AI</searchLink>; Johns Hopkins Medical Institutions, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Bookman+MA%22">Bookman MA</searchLink>; Arizona Cancer Center, Tucson, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+DK%22">Armstrong DK</searchLink>; Johns Hopkins Medical Institutions, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tanner+EJ%22">Tanner EJ</searchLink>; Johns Hopkins Medical Institutions, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Gershenson+DM%22">Gershenson DM</searchLink>; University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2014 Mar; Vol. 132 (3), pp. 560-5. <i>Date of Electronic Publication: </i>2013 Dec 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=24333362
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2013.11.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 560
    Titles:
      – TitleFull: The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fader AN
      – PersonEntity:
          Name:
            NameFull: Java J
      – PersonEntity:
          Name:
            NameFull: Krivak TC
      – PersonEntity:
          Name:
            NameFull: Bristow RE
      – PersonEntity:
          Name:
            NameFull: Tergas AI
      – PersonEntity:
          Name:
            NameFull: Bookman MA
      – PersonEntity:
          Name:
            NameFull: Armstrong DK
      – PersonEntity:
          Name:
            NameFull: Tanner EJ
      – PersonEntity:
          Name:
            NameFull: Gershenson DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2014 Mar
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-electronic
              Value: 1095-6859
          Numbering:
            – Type: volume
              Value: 132
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Gynecologic oncology
              Type: main
ResultId 1